<VariationArchive VariationID="533549" VariationName="NM_025243.4(SLC19A3):c.597dup (p.His200fs)" VariationType="Duplication" Accession="VCV000533549" Version="9" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-23" DateCreated="2018-05-28" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="517859" VariationID="533549">
      <GeneList>
        <Gene Symbol="SLC19A3" FullName="solute carrier family 19 member 3" GeneID="80704" HGNC_ID="HGNC:16266" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q36.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227683763" stop="227718028" display_start="227683763" display_stop="227718028" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="228549925" stop="228582744" display_start="228549925" display_stop="228582744" Strand="-" />
          </Location>
          <OMIM>606152</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025243.4(SLC19A3):c.597dup (p.His200fs)</Name>
      <CanonicalSPDI>NC_000002.12:227699117:AAAAAA:AAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q36.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227699117" stop="227699118" display_start="227699117" display_stop="227699118" variantLength="1" positionVCF="227699117" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="228563833" stop="228563834" display_start="228563833" display_stop="228563834" variantLength="1" positionVCF="228563833" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>H200fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.228563839dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.228563839dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.227699123dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.227699123dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016359.1" sequenceAccession="NG_016359" sequenceVersion="1" change="g.23912dup">
            <Expression>NG_016359.1:g.23912dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025243.4" sequenceAccession="NM_025243" sequenceVersion="4" change="c.597dup" MANESelect="true">
            <Expression>NM_025243.4:c.597dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079519.1" sequenceAccession="NP_079519" sequenceVersion="1" change="p.His200fs">
            <Expression>NP_079519.1:p.His200fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025243.3" sequenceAccession="NM_025243" sequenceVersion="3" change="c.597dupT">
            <Expression>NM_025243.3:c.597dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA431664295" DB="ClinGen" />
        <XRef Type="rs" ID="773140674" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025243.4(SLC19A3):c.597dup (p.His200fs) AND Biotin-responsive basal ganglia disease" Accession="RCV000640712" Version="6">
        <ClassifiedConditionList TraitSetID="1254">
          <ClassifiedCondition DB="MedGen" ID="C1843807">Biotin-responsive basal ganglia disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-02" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025243.4(SLC19A3):c.597dup (p.His200fs) AND not provided" Accession="RCV001268315" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-10-20" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-02" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2018-05-28" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23423671</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23482991</ID>
        </Citation>
        <DescriptionHistory Dated="2020-11-27">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1254" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="585" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- AND THIAMINE-RESPONSIVE TYPE)</ElementValue>
                <XRef Type="MIM" ID="607483" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thiamine Transporter-2 Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">thiamine-responsive encephalopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Biotin-thiamine-responsive basal ganglia disease</ElementValue>
                <XRef ID="Basal+Ganglia+Disease%2C+Biotin-Responsive/756" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Biotin-responsive basal ganglia disease</ElementValue>
                <XRef ID="MONDO:0011841" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thiamine metabolism dysfunction syndrome type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BBGD</ElementValue>
                <XRef Type="MIM" ID="607483" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">THMD2</ElementValue>
                <XRef Type="MIM" ID="607483" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">BBTGD</ElementValue>
                <XRef Type="MIM" ID="607483" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Biotin-thiamine-responsive basal ganglia disease (BTBGD) may present in childhood, early infancy, or adulthood. The classic presentation of BTBGD occurs in childhood (age 3-10 years) and is characterized by recurrent subacute encephalopathy manifest as confusion, seizures, ataxia, dystonia, supranuclear facial palsy, external ophthalmoplegia, and/or dysphagia which, if left untreated, can eventually lead to coma and even death. Dystonia and cogwheel rigidity are nearly always present; hyperreflexia, ankle clonus, and Babinski responses are common. Hemiparesis or quadriparesis may be seen. Episodes are often triggered by febrile illness or mild trauma or stress. Simple partial or generalized seizures are easily controlled with anti-seizure medication. An early-infantile Leigh-like syndrome / atypical infantile spasms presentation occurs in the first three months of life with poor feeding, vomiting, acute encephalopathy, and severe lactic acidosis. An adult-onset Wernicke-like encephalopathy presentation is characterized by acute onset of status epilepticus, ataxia, nystagmus, diplopia, and ophthalmoplegia in the second decade of life. Prompt administration of biotin and thiamine early in the disease course results in partial or complete improvement within days in the childhood and adult presentations, but most with the infantile presentation have had poor outcome even after supplementation with biotin and thiamine.</Attribute>
                <XRef ID="NBK169615" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10237" />
                <XRef ID="10237" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24260777</ID>
                <ID Source="BookShelf">NBK169615</ID>
              </Citation>
              <XRef ID="199348" DB="Orphanet" />
              <XRef ID="65284" DB="Orphanet" />
              <XRef ID="C1843807" DB="MedGen" />
              <XRef ID="MONDO:0011841" DB="MONDO" />
              <XRef Type="MIM" ID="607483" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1472044" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="2586971|MedGen:C1843807" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000762310" DateUpdated="2024-02-14" DateCreated="2018-05-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23423671</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23482991</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.His200Serfs*25) in the SLC19A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC19A3 are known to be pathogenic (PMID: 23423671, 23482991). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with SLC19A3-related conditions. ClinVar contains an entry for this variant (Variation ID: 533549). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC19A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.228563833_228563834insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1843807" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB3864685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2857536" SubmissionDate="2020-10-23" DateLastUpdated="2020-11-28" DateCreated="2020-11-28">
        <ClinVarSubmissionID localKey="report_configuration_variant_id:435" />
        <ClinVarAccession Accession="SCV001447148" DateUpdated="2020-11-28" DateCreated="2020-11-28" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Applied Genomics, University Hospital TÃ¼bingen" OrgID="506385" OrganizationCategory="laboratory" OrgAbbreviation="IMGAG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Unknown mechanism</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SampleLocalID">DX182833</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0003287" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0007146" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0030085" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="GA" referenceAllele="G" start="228563833" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3878912" SubmissionDate="2021-10-15" DateLastUpdated="2021-10-30" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="NM_025243.3:c.597dup|Biotin-thiamine-responsive basal ganglia disease" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001984786" DateUpdated="2021-10-30" DateCreated="2021-10-30" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshifting variant in exon 3 of 6 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has been previously reported as a compound heterozygous change in a patient with biotin-responsive basal ganglia disease (BBGD) (PMID: 32020600). It is present in the heterozygous state in the gnomAD population database at a frequency of 0.0004% (1/251442) and thus is presumed to be rare. Based on the available evidence, the c.597dup (p.His200SerfsTer25) variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC19A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025243.3:c.597dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Biotin-thiamine-responsive basal ganglia disease</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10524990</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5461094" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_025243.4:c.597dup|OMIM:607483" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002811008" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025243.4:c.597dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607483" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4898126" SubmissionDate="2022-04-27" DateLastUpdated="2023-03-04" DateCreated="2022-04-29">
        <ClinVarSubmissionID localKey="GDXSV:226033" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002504476" DateUpdated="2023-03-04" DateCreated="2022-04-29" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Not observed at significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 32020600, 31589614, 32600842, 34426522, 34077649)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC19A3" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2803248</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025243.3:c.597dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_103_20220427054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2857536" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007146" MappingRef="HP">
        <MedGen CUI="C4024932" Name="Bilateral basal ganglia lesions" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3878912" TraitType="Disease" MappingType="Name" MappingValue="Biotin-thiamine-responsive basal ganglia disease" MappingRef="Preferred">
        <MedGen CUI="C1843807" Name="Biotin-responsive basal ganglia disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857536" TraitType="Finding" MappingType="XRef" MappingValue="HP:0030085" MappingRef="HP">
        <MedGen CUI="C4022656" Name="Abnormal CSF lactate concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1472044" TraitType="Disease" MappingType="XRef" MappingValue="C1843807" MappingRef="MedGen">
        <MedGen CUI="C1843807" Name="Biotin-responsive basal ganglia disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857536" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4898126" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5461094" TraitType="Disease" MappingType="XRef" MappingValue="607483" MappingRef="OMIM">
        <MedGen CUI="C1843807" Name="Biotin-responsive basal ganglia disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857536" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003287" MappingRef="HP">
        <MedGen CUI="C4021734" Name="Abnormality of mitochondrial metabolism" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

